Abstract
Abstract Disparities in outcomes after hematopoietic cell transplant (HCT) are reported mostly by registry studies. We examined the association of self-reported race and ethnicity with outcomes and health care utilization after allogeneic HCT in a single center study. Clinical and socioeconomic data of 296 adult patients who underwent allogeneic HCT from November 2003 to October 2012 were analyzed. Survival was compared between non-Hispanic Whites (NHW) and minority patients using Cox proportional hazards regression. Some 73% of patients were NHW and 27% were racial/ethnic minority patients. More minority patients were younger and had lower socioeconomic status. Both unadjusted and adjusted overall and progression-free survival were comparable between the two groups. High risk disease, poor performance score and Medicare/Tricare were significant predictors of mortality. Health care utilization was comparable between the two groups. Homogeneity of medical care for allogeneic HCT may help overcome racial/ethnic disparities, but not those due to patients' primary insurance.
Original language | English (US) |
---|---|
Pages (from-to) | 987-992 |
Number of pages | 6 |
Journal | Leukemia and Lymphoma |
Volume | 56 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2015 |
Keywords
- Disparities
- Health care utilization
- Hematopoietic cell transplant
- Race/ethnicity
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research